Pay in 4 interest-free payments of $5.76 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
Physician-Backed Solutions Meet the Founder "As a physician specializing in metabolic health and obesity medicine, I've created these products to address the root causes of metabolic dysfunction
To date, these GLP-1 drugs have been approved to treat three adult populations: individuals with type 2 diabetes, individuals with a body mass index (BMI) of 30 or greater (obesity), and individuals with a BMI between 27 and 30 (overweight) with at least one weight-related health condition, such as cardiovascular disease, high blood pressure, high cholesterol, prior stroke, prior heart attack, and chest pain (angina)
K., Goodman, R
The medication supports the work, but its not the whole treatment
As microdosing is an experimental practice, it is essential to consult a licensed healthcare provider for medical advice before using it for weight management or blood sugar control, to reduce the risk and ensure safety
Research indicates that a meaningful percentage of weight lost on GLP-1 receptor agonists can come from lean tissue rather than adipose tissue, particularly without resistance guidance, adequate protein intake, or physician-directed dose titration
US$ 28.71
US$ 25.57
US$ 28.84
US$ 20.64
US$ 24.64
